| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Chronic Myelogenous Leukemia: Monitoring Response to Therapy
|
Branford, Susan
|
|
2011
|
6 |
2 |
p. 75-81
|
artikel
|
| 2 |
In Search of CML Stem Cells’ Deadly Weakness
|
Pellicano, Francesca
|
|
2011
|
6 |
2 |
p. 82-87
|
artikel
|
| 3 |
Is Subcutaneous Bortezomib Ready for Prime Time?
|
Lonial, Sagar
|
|
2011
|
6 |
2 |
p. 73-74
|
artikel
|
| 4 |
Management of Lower-Risk Myelodysplastic Syndromes:The Art and Evidence
|
Komrokji, Rami S.
|
|
2011
|
6 |
2 |
p. 145-153
|
artikel
|
| 5 |
New Drugs for Chronic Myelogenous Leukemia
|
Santos, Fabio P. S.
|
|
2011
|
6 |
2 |
p. 96-103
|
artikel
|
| 6 |
New Immunomodulatory Drugs in Myeloma
|
Lacy, Martha Q.
|
|
2011
|
6 |
2 |
p. 120-125
|
artikel
|
| 7 |
Predicting the Response of CML Patients to Tyrosine Kinase Inhibitor Therapy
|
White, Deborah L.
|
|
2011
|
6 |
2 |
p. 88-95
|
artikel
|
| 8 |
The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate
|
Steensma, David P.
|
|
2011
|
6 |
2 |
p. 136-144
|
artikel
|
| 9 |
Treatment of Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients
|
Kumar, Shaji
|
|
2011
|
6 |
2 |
p. 104-112
|
artikel
|
| 10 |
Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation
|
Mateos, M. Victoria
|
|
2011
|
6 |
2 |
p. 113-119
|
artikel
|
| 11 |
Updates in Cytogenetics and Molecular Markers in MDS
|
Tiu, Ramon V.
|
|
2011
|
6 |
2 |
p. 126-135
|
artikel
|
Tijdschrift beschrijving